NCT02279394 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Adverse Events assessed/monitored from the day of consent up to the end of treatment for an average of 26 months All-Cause Mortality as well as Serious Adverse Events were collected up to +/- 60 months. These duration may vary individually based on possible dose delays as well as follow up study visit delays or some participants possibly coming off study early.
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Elo / Len / Dex | 8 / 40 | 40 / 40 | 2 / 40 |
| Elo / Len | 1 / 11 | 11 / 11 | 0 / 11 |
Serious adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 40
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hypophosphatemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Neutrophil count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 40
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Cholecystitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Lymphocyte count increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Diabetic ketoacidosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hyperglycemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Sepsis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hypophosphatemia
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 36
- num At Risk
- 40
- num Events
- 72
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 11
- num Events
- 47
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 40
- num Events
- 70
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 24
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 40
- num Events
- 82
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 11
- num Events
- 43
- term
- Hyperglycemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 40
- num Events
- 97
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 11
- term
- White blood cell decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 21
- num At Risk
- 40
- num Events
- 28
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 7
- term
- Insomnia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 20
- num At Risk
- 40
- num Events
- 29
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 17
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 40
- num Events
- 48
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 13
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 40
- num Events
- 78
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 11
- num Events
- 26
- term
- Hypophosphatemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 40
- num Events
- 33
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 11
- term
- Upper respiratory infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 40
- num Events
- 29
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 16
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 19
- num At Risk
- 40
- num Events
- 131
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 11
- num Events
- 28
- term
- Neutrophil count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 40
- num Events
- 71
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 11
- num Events
- 16
- term
- Platelet count decreased
Complete source fields
- event Groups
- deaths Num Affected
- 2
- deaths Num At Risk
- 40
- description
- •Drug: Elotuzumab 10 mg/kg IV; Days 1, 8,15, 22 Cycles 1-2 10 mg/kg IV; Days 1 \& 15 Cycles 3-8 Other Name: HuLuc63 •Drug: Lenalidomide 25 mg Oral; Days 1-21 days Cycles 1-24 Other Name: REVLIMID •Drug: Dexamethasone 40 mg Oral; Days 1, 8, 15, 22 Cycles 1-2 40 mg Oral; Days 1, 8, 15 Cycles 3-8 Other Name: Decadron Elotuzumab: 10 mg/kg IV; Days 1, 8,15, 22 Cycles 1-2 10 mg/kg IV; Days 1 \& 15 Cycles 3-8 Lenalidomide: 25 mg Oral; Days 1-21 days Cycles 1-24 Dexamethasone: 40 mg Oral; Days 1, 8, 15, 22 Cycles 1-2 40 mg Oral; Days 1, 8, 15 Cycles 3-8
- id
- EG000
- other Num Affected
- 40
- other Num At Risk
- 40
- serious Num Affected
- 8
- serious Num At Risk
- 40
- title
- Elo / Len / Dex
- deaths Num Affected
- 0
- deaths Num At Risk
- 11
- description
- •Drug: Elotuzumab 10 mg/kg IV; Days 1, 8,15, 22 Cycles 1-2 10 mg/kg IV; Days 1 \& 15 Cycles 3-8 Other Name: HuLuc63 •Drug: Lenalidomide 25 mg Oral; Days 1-21 days Cycles 1-24 Other Name: REVLIMID Elotuzumab: 10 mg/kg IV; Days 1, 8,15, 22 Cycles 1-2 10 mg/kg IV; Days 1 \& 15 Cycles 3-8 Lenalidomide: 25 mg Oral; Days 1-21 days Cycles 1-24
- id
- EG001
- other Num Affected
- 11
- other Num At Risk
- 11
- serious Num Affected
- 1
- serious Num At Risk
- 11
- title
- Elo / Len
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 36
- num At Risk
- 40
- num Events
- 72
- group Id
- EG001
- num Affected
- 11
- num At Risk
- 11
- num Events
- 47
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 32
- num At Risk
- 40
- num Events
- 70
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 24
- term
- Diarrhea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 23
- num At Risk
- 40
- num Events
- 82
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 11
- num Events
- 43
- term
- Hyperglycemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 22
- num At Risk
- 40
- num Events
- 97
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 11
- term
- White blood cell decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Psychiatric disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 21
- num At Risk
- 40
- num Events
- 28
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 7
- term
- Insomnia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 20
- num At Risk
- 40
- num Events
- 29
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 17
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 40
- num Events
- 48
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 13
- term
- Anemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 40
- num Events
- 78
- group Id
- EG001
- num Affected
- 8
- num At Risk
- 11
- num Events
- 26
- term
- Hypophosphatemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 18
- num At Risk
- 40
- num Events
- 33
- group Id
- EG001
- num Affected
- 5
- num At Risk
- 11
- num Events
- 11
- term
- Upper respiratory infection
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 16
- num At Risk
- 40
- num Events
- 29
- group Id
- EG001
- num Affected
- 6
- num At Risk
- 11
- num Events
- 16
- term
- Constipation
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 19
- num At Risk
- 40
- num Events
- 131
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 11
- num Events
- 28
- term
- Neutrophil count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 17
- num At Risk
- 40
- num Events
- 71
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 11
- num Events
- 16
- term
- Platelet count decreased
- serious Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 40
- num Events
- 3
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hypophosphatemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Neutrophil count decreased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Hepatobiliary disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 40
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 11
- num Events
- 1
- term
- Cholecystitis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Eye disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Cataract
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Lymphocyte count increased
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Myocardial infarction
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Diabetic ketoacidosis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Metabolism and nutrition disorders
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hyperglycemia
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Infections and infestations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Sepsis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Investigations
- source Vocabulary
- CTCAE (4.0)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 40
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 11
- num Events
- 0
- term
- Hypophosphatemia
- time Frame
- Adverse Events assessed/monitored from the day of consent up to the end of treatment for an average of 26 months All-Cause Mortality as well as Serious Adverse Events were collected up to +/- 60 months. These duration may vary individually based on possible dose delays as well as follow up study visit delays or some participants possibly coming off study early.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle